Cellumed Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellumed Co Ltd with three other
companies in this sector in South Korea:
ISU Abxis Company Limited
sales of 11.47 billion Korean Won [US$10.20 million]
of which 100%
was Antibody Medicine),
(18.57 billion Korean Won [US$16.51 million]
of which 78%
was The clinical trial agent), and
Viromed Company Ltd
(7.70 billion Korean Won [US$6.84 million]
Cellumed Co Ltd reported sales of 17.73 billion Korean Won (US$15.76 million)
December of 2015.
decrease of 14.5%
versus 2014, when the company's sales were 20.73 billion Korean Won.